NATIONAL HARBOR, Maryland — The latest advancements in obesity medicine and metabolic surgery will come together at the annual Obesity Week meeting, with scientific sessions kicking off here on Sunday at the Gaylord National Resort & Convention Center.
With expectations of nearly 4,500 attendees, this year’s meeting — jointly hosted by The Obesity Society and the American Society for Metabolic and Bariatric Surgery — will showcase new research from behavioral health to nutrition and pharmacotherapy.
For example, among the clinical study topics to be presented during a session on Thursday are the following:
- The relationship between cancer risk and bariatric surgery-induced weight loss
- How the effectiveness of bariatric procedures stack up
- A primary care-based “toolbox approach” to treating obesity
- Directive support in aiding weight loss
- Anti-obesity medication use in adults
In one of two late breaking oral sessions on Wednesday, researchers will focus on the factors that promote obesity, including individual influences such as glutamatergic neurons and even the characteristics of a college roommate, as well as large-scale impacts such as the gross national income and the environment.
Prevention of obesity with a focus on weight loss will be the highlight of another late breaking oral session that day, with topics such as amylin and GLP-1 combination therapy, lorcaserin with lifestyle modification, the “Starting Early Program” for obesity prevention in infants, and persistent metabolic adaption with weight loss.
“New for 2017, we will offer two ‘Key Topics from Different Perspectives’ throughout the conference,” the chair of the annual scientific program committee for The Obesity Society, Jeffrey Zigman, MD, PhD, told MedPage Today via email. “In particular, Physical Activity/Exercise and Dietary Interventions will be covered from the perspectives of Metabolism & Integrative Physiology, Neuroscience, Intervention & Clinical Studies, Population Health, Clinical/Professional Practice, and Health Care Policy/Public Health Policy.”
“There will be many outstanding sessions over the course of the conference,” he added. “Some of the highlights, in my mind, will be the Opening Keynote lecture given by world-renowned obesity researcher Dr. Rudolph Leibel, entitled, ‘Stem cell-derived hypothalamic neurons in the elucidation of the pathogenesis of human obesity: a new frontier.'”
Zigman also suggested that attendees in the neurology field check out lectures to be given by Harvey Grill, PhD (“Treating the hyperphagia driving obesity — neural mechanisms of feeding inhibition”) and Joel Elmquist, DVM, PhD, on hypothalamic integration of metabolism and exercise.
Not-to-be-missed symposia highlighted by Zigman include the final results of the Childhood Obesity Prevention and Treatment Research (COPTR) trials, to be presented on Wednesday; the implications of policy and public health on food choices; and “clinical pearls” from bariatric experts.
“Besides the science, there will be many other opportunities for networking and having fun,” Zigman added. “The Welcome Reception will feature a costume contest, and the AfterDark Party will feature an extremely fun, high-energy live band.”